Price $2.78 |
Market Cap
41.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.05
|
P/S
3.74
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-59.7K
|
FCF
-12.9
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-301.00%
|
ROI
-171.40%
|
|
ROA
-163.20%
|
EPS Growth
-27.50%
|
Current Ratio
3.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biomerica Inc (BMRA) | $1.87 | - | - | 37.5M | Strong Buy |
| Applied DNA Sciences Inc (APDN) | $1.10 | - | - | 17.7M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.19 | - | - | 129.6M | Strong Buy |
| Anika Therapeutics Inc (ANIK) | $28.12 | - | - | 459.3M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $12.40 | - | - | 495M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
